This brand name is authorized in Estonia, Lithuania, Poland.
The drug TRUBERZI contains one active pharmaceutical ingredient (API):
1
|
UNII
45TPJ4MBQ1 - ELUXADOLINE
|
|
Eluxadoline is a locally acting, mixed mu opioid receptor (μOR) agonist and delta opioid receptor (δOR) antagonist. Eluxadoline is also an agonist at the kappa opioid receptor (κOR). Eluxadoline has demonstrated efficacy in normalizing GI transit and defecation in several models of stress induced or post GI inflammation-altered GI function in animals. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| A07DA06 | A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07D Antipropulsives → A07DA Antipropulsives | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| EE | Ravimiamet | 1729188, 1729199, 1729201, 1729212, 1761296, 1761308 |
| LT | Valstybinė vaistų kontrolės tarnyba | 1081079, 1081080, 1081081, 1081082, 1085357, 1085358 |
| PL | Rejestru Produktów Leczniczych | 100377428, 100377434 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.